Chapter 57 – Pulmonary Vasodilators
暂无分享,去创建一个
[1] N. Voelkel,et al. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? , 2000, The Journal of clinical investigation.
[2] L. Rubin,et al. Primary pulmonary hypertension. , 1997, The New England journal of medicine.
[3] M. Juhaszova,et al. Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells. , 1997, The Journal of clinical investigation.
[4] J. Barberà,et al. Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[5] P. Wagner,et al. Effects of inhaled nitric oxide on gas exchange in lungs with shunt or poorly ventilated areas. , 1997, American journal of respiratory and critical care medicine.
[6] M. Yoshida,et al. Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[7] L. Rubin. The renin-angiotensin system and the "lesser circulation". A role in cor pulmonale? , 1996, Chest.
[8] J. Barberà,et al. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease , 1996, The Lancet.
[9] Y. Castaing,et al. Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.
[10] S. Adnot,et al. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. , 1993, The American review of respiratory disease.
[11] P. Frith,et al. Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease. , 1993, Chest.
[12] R. Rossaint,et al. Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.
[13] G. Domenighetti,et al. Short- and long-term hemodynamic effects of oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease. , 1992, Chest.
[14] D. Magometschnigg,et al. Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil. , 1990, Chest.
[15] L. Rubin,et al. Effects of nitrendipine and hypoxia on pulmonary vascular resistance in experimental emphysema. , 1990, The American review of respiratory disease.
[16] P. Agostoni,et al. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.
[17] P. Surpas,et al. One-year clinical study on nifedipine in the treatment of pulmonary hypertension in chronic obstructive lung disease. , 1988, Respiration; international review of thoracic diseases.
[18] O. Burghuber. Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in patients with chronic obstructive pulmonary disease. , 1987, Respiration; international review of thoracic diseases.
[19] F. Khaja,et al. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. , 1985, Annals of internal medicine.
[20] E. K. Weir,et al. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension. , 1983, The American journal of cardiology.